MSOS Stock analysis – The DEA Announcement & M&A Activity

Enterosignatures provide an interpretable and generic model that enables an intuitive characterization of gut microbiome composition

Researchers used a diverse set of 5,230 gut metagenomes to train a study model.

June 21, 2023

Tolinapant by Astex Pharmaceuticals for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

May 17, 2024

Study shows dramatic increase in daily cannabis use in the United States

Many countries around the world are considering revising cannabis policies. A new study by a researcher at Carnegie Mellon University assessed cannabis use in the

May 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.